GlassScriptPhysician profile
Anna Hegge
NPI 1285013748
$3,144.49
in general payments reported to CMS, 2019-2025
26 companies · $18.72 in 2025
The $18.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $251 · 2021: $774 · 2022: $696 · 2023: $753 · 2024: $388 · 2025: $18.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.18 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.71 | 2019-2023 | |
| Agile Therapeutics, INC. | $336.22 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $254.01 | 2020-2024 | Slynd |
| Astellas Pharma US INC | $217.56 | 2022-2024 | Veozah, Myrbetriq |
| Amgen INC. | $206.04 | 2019-2024 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $170.64 | 2020-2025 | Aptima, Myosure Tissue Removal Device, Affirm Prone Biopsy System |
| Baxter Healthcare | $168.44 | 2019-2020 | |
| Myovant Sciences INC. | $163.16 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $162.03 | 2021-2024 | |
| Pfizer INC. | $161.73 | 2020-2024 | |
| Therapeuticsmd, INC. | $113.54 | 2020-2022 | |
| Shield Therapeutics INC | $104.39 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $92.65 | 2020-2023 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $80.87 | 2019-2023 | |
| Organon LLC | $71.90 | 2021-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $68.82 | 2020-2023 | Gardasil 9 |
| Sumitomo Pharma America, INC. | $57.78 | 2023-2024 | Myfembree |
| Exact Sciences Corporation | $55.90 | 2023-2024 | Cologuard Collection Kit |
| Scynexis, INC. | $55.31 | 2022 | |
| Mylan Pharmaceuticals INC. | $31.59 | 2021 | |
| Amag Pharmaceuticals, INC. | $27.44 | 2019 | |
| Minerva Surgical, INC | $27.22 | 2021-2023 | |
| Becton, Dickinson and Company | $22.82 | 2021 | |
| Novo Nordisk INC | $21.46 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.17 | 2019 | |
| Lupin INC. | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hegge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.